MUC5AC [apparent molecular weight (i&) 500,OOOl and MUC6 (apparent Mr 400,000) were detected in the stomach but not in the small or large intestine, MUC3 (apparent M;-550,000) was detected in duodenum and jejunum, MUC2 (apparent Mr 600,000) was detected throughout the small and large intestine, and MUC4 (apparent Mr >900,000) was detected predominantly in the large intestine. Interestingly, some individuals displayed double bands of MUC2 and MUC3 precursors, suggesting allelic variation within the respective genes. Between small and large intestine mature secreted MUC2 showed differences in mobility on SDS-PAGE, suggesting differences in glycosylation. Each of the MUC2, MUC3, MUC4, MUC5AC, and MUC6 precursors could be distinguished electrophoretically, and each showed region-specific expression along the gastrointestinal tract.
biosynthesis; mucins; human; gastrointestinal tract MUCOSAE OF THE INTESTINE and stomach are covered by a mucus gel layer that protects the epithelium against mechanical damage and chemical irritants (35) . Mucus glycoproteins, often referred to as mucins, are synthesized by the mucosal epithelium and form the most important structural component of mucus (12). The class of epithelial mucins can be divided into either secretory or membrane-bound mucins (reviewed in Refs. 29, 40). The central part of the polypeptide backbones of these molecules consists of many tandemly repeated amino acid sequences that are rich in serine and threonine residues; these tandem repeats are unique for each mucin, may vary in number between individuals, and are densely 0-glycosylated. The NH2 and COOH terminals of the mucin polypeptides protrude from the heavily 0-glycosylated central part, do not contain tandem repeats, and, for secretory mucins, contain many cysteine residues forming interand intramolecular disulfide bonds. Usually the terminals of the polypeptides have some N-glycosylation (29). Due to diverse 0-glycosylation, each mucin gene product forms a heterogeneous set of molecules. Several different human epithelial mucin genes have been identified, named MUCl-8.
MUCl, which has been fully sequenced, codes for a membrane-bound mucin (14, 23, 24); MUCZ and MUC7 cDNAs have been completely sequenced and code for secretory mucins (2, 15, 17). Only partial cDNA sequences are known for MUC3, MUC4, MUC5AC, MUCSB, MUC6, and MUC8 (11, 16, 18, (26) (27) (28) 32) . Of these, MUCSAC codes for a secretory mucin and is expressed at a high level in the human stomach (4,21,22). The question of whether the other cDNAs encode secretory mucins has to await their full sequence determination and cell biological assessment of the secretory status of each of these mucins.
Mucin expression is tissue as well as cell type specific. For instance, in the small intestine, MUCZ and MUC3 mRNAs are prominently expressed; MUCZ is confined to goblet cells, whereas MUC3 is largely confined to enterocytes (6). In the human large intestine MUC2 is the prominent mucin (34), whereas in the stomach, which also produces a copious mucin layer, MUC2 is hardly detectable (1,19). In addition to MUCZ and MUC3, several other mucins, namely MUCl, MUC4, MUCSAC, MUCSB, and MUC6, are expressed to some extent in the intestine (1, 19, 41; see Refs. 40 and 42 for review). Interestingly, in the glands of the human stomach, MUC6 protein is also detectable (8), whereas MUC5AC protein seems restricted to the superficial epithelium of the stomach (5,21,22). Of the other known mucins MUC8 is not expressed in the small intestine and MUC7 expression seems restricted to the salivary glands (2,28).
Alterations in intestinal mucins, especially in glycosylation patterns and expression levels, have been associated with diseases such as inflammatory bowel disease and carcinoma (3, 7, 13, 19, 35, 37, 39) . Whether these alterations are the result or the cause of disease is presently unclear.
So far, studies of gastrointestinal mucins have focused on steady-state levels of mRNA and protein by means of in situ hybridization, Northern blotting, or immunohistochemistry.
Little is known about the biosynthesis of gastrointestinal mucins: only the predominant human colonic and gastric mucins, which were G296 were performed for 4 h by washing the production, purification, and specificity analysis are similar biopsies and then adding 100 ~1 complete medium per biopsy, to those described for the MUC6.1 antibody (C. de Bolos, A.
containing an excess of unlabeled precursor. Lopez-Ferrer, M. Garrido, and F. X. Real, unpublished obserAfter the respective pulse or chase experiments, explants vations). For a summary of the antibodies see Table I . were washed once with phosphate-buffered saline (PBS) and Tissues. All samples were taken from healthy tissues: homogenized at 0°C in buffer containing 50 mM tris(hydroxybiopsies from stomach antrum, human duodenum (lo-20 cm methyl)aminomethane (Tris), pH 7.5, 5 mM EDTA, 1% (wtl distal from the pylorus), ascending colon, transverse colon, vol) Triton X-100, as well as 1 mM PMSF, 100 pg/ml pepstatin and sigmoid colon (30 cm proximal to the anus) were obtained A, 100 pg/ml leupeptin, 10 mM iodacetamide, and 0.24 U/ml by endoscopy. Samples of healthy proximal jejunum (9 indiaprotinin. Immunocomplexes were precipitated using Sepharose CL-4B-coupled protein A. Immunoprecipitated mucins were washed, reduced, and analyzed by SDS-PAGE using 3% stacking and 4% running gels as previously described (10,34). For molecular weight markers, unreduced rat gastric mucin precursors labeled with 35S-labeled amino acids were used, with molecular masses of -300 kDa for the monomer and 600 kDa for the dimer (9). Prestained high molecular weight markers, with molecular masses between 49.5 and 205 kDa, were used. Additionally, mouse laminin, molecular mass 900 kDa, was used as a marker. Gels were fixed in 10% methanol and 10% acetic acid and incubated for 10 min with Amplify. Radiolabeled mucins were analyzed by fluorography; the films (Biomax MR) were exposed for l-4 wk at -70°C.
RESULTS
Gastrointestinal mucin precursors are synthesized region specifically and can be distinguished by SDS-PAGE. By pulse labeling with [35Slmethionine/cysteine of human gastrointestinal biopsies and immunoprecipitations, we studied the biosynthesis of mucin precursors along the human gastrointestinal tract. For the purpose of this study, we define mucin precursors as mucin proteins that are N-glycosylated
but not yet 0-glycosylated and that are present in the rough endoplasmic reticulum, whereas mature mucins are the fully 0-glycosylated end products of biosynthesis (29). Molecular masses of the mucin precursors that contain N-glycans presented in this study are represented as apparent molecular masses. Actual molecular masses may differ from apparent molecular masses on SDS-PAGE, since it is difficult to accurately estimate the molecular masses of these very large proteins on SDS-PAGE. Moreover, in this very high molecular weight range there are very few molecular weight markers.
The antisera directed against a synthetic peptide of MUC5AC [anti-MUCXAC(l)l or against rat gastric mucin [anti-MUC%AC(2)1 both detect a mucin precursor of similar apparent molecular mass in the stomach of the same individual, visible as a band of -500 kDa on SDS-PAGE (Fig. 1A) . Moreover, in the gastric homogenate of the same individual this mucin precursor is easily detected, suggesting that it is a predominant mucin biosynthesized in the stomach (Fig. 1A) . In 3 of 3 individuals we detected MUC5AC precursors in the stomach (Table 2 ). MUC6 precursors were detected in the stomach in 3 of 3 individuals, with apparent molecular mass of 400 kDa (Fig. 1A) . In the LS 174T cell line, a colon adenocarcinoma cell line, MUC6 precursors have similar apparent molecular mass as determined by SDS-PAGE (41). No MUC5AC or MUC6 precursors could be detected in the small or large intestine of different individuals (Fig. 1B and Table 2 ).
MUC2 precursors (apparent molecular mass of -600 kDa) were immunoprecipitated by different anti-MUC2 antibodies from homogenates of duodenum, jejunum, and sigmoid colon (Fig. 1B) . Similar results were obtained by the anti-MUC2 monoclonal antibody, anti-MUGS(1) (data not shown). In fact, MUC2 precursors were detected in both the small and large intestine of each of the individuals examined (Table 2) . In some cases, MUC2 precursors could be detected as double bands on SDS-PAGE, for instance, in the jejunum of one individual (Fig. 1B) . In 3 of 38 individuals we detected double bands for MUC2 precursors (Table 2 ). In the duodenum of one individual and the jejunum of another, MUC3 precursors were detected as a double and a single band, respectively, at -550 kDa (Fig. 1B) . In the Caco-2 cell line, a colon adenocarcinoma cell line, MUC3 precursors displayed similar apparent molecular mass on SDS-PAGE (41). In the stomach and colon no MUC3 precursors were detected (Table 2) . Interestingly, in one individual we found double bands of MUC3 precursors in two organs, the jejunum and the gallbladder (not shown). In 5 of 17 individuals we could show double bands of MUC3 precursors (Table 2) . One individual displayed double bands for both MUC2 and MUC3 precursors (not shown). In jejunum, MUC4 precursors were detectable, migrating halfway in the stacking gel on SDS-PAGE (Fig.  1B) . MUC4 precursors were also immunoprecipitated from homogenates of the sigmoid colon but not from the duodenum (Fig. 1B ) . Electrophoresis was performed for twice the period of time for analysis of MUC4 precursors in the sigmoid colon compared with analysis of MUC4 precursors in the jejunum (Fig. lB) , thus enabling MUC4 precursors to enter the running gel. The apparent molecular mass of MUC4 precursors was estimated at >900 kDa, because the M, appeared higher than that of mouse laminin (M, 900,000) on SDS-PAGE.
We detected MUC4 precursor in the jejunum of one individual and in the sigmoid colon in 11 of 12 individuals, but not in the stomach or duodenum of different individuals (Table 2 ). In the ascending colon, however, only 1 of 3 individuals expressed MUC4, and in the transverse colon no MUC4 precursors were detected (Table 2) . Strikingly, no double bands were detected on SDS-PAGE for MUC4, MUCZAC, and MUC6 (Table 2) .
Mobility on SDS-PAGE suggests that MUC2 is glycosylated differently in the small and large intestine. Intestinal biopsies were pulse labeled with radiolabeled amino acids, sulfate, or galactose and chase incubated. The biosynthesis of mature MUC3, MUC4, and MUC6 could not be studied, because the available antibodies against the respective mucins were directed against the tandemly repeated amino acid sequences, which become masked upon 0-glycosylation.
The biosynthesis of mature MUC5AC in the stomach has been documented previously (22) . After pulse labeling with [35Slmethionine/cysteine and immunoprecipitation with anti-MUC2
(2), MUC2 precursors were immunoprecipitated from the homogenate of the duodenum and detected at -600 kDa on SDS-PAGE ( Fig. 2A) . This band became fainter after a 4-h chase incubation compared with the band after no chase incubation, due to conversion into mature fully 0-glycosylated mucin. Mature MUC2 was secreted into the medium, visible as a smear just entering the stacking gel ( Fig. 2A, lane  m4) . This indicates that the mature MUC2 synthesized in the duodenum has a very low mobility on SDS-PAGE. Similar results were obtained for the jejunum (not shown). After pulse labeling with [35S]methionine/ cysteine, MUC2 precursor was immunoprecipitated from the sigmoid colon homogenate, visible as a band at 600 kDa on SDS-PAGE (Fig. 2B) . After a 4-h chase incubation, a short smear was detectable just below the MUC2 precursor with a mobility of 550 kDa, which represents the mature fully glycosylated MUC2 that was immunoprecipitated from the tissue homogenate. This mature MUC2 was also secreted into the medium, whereas the MUC2 precursor was not secreted (Fig.  2B, lane m4) .
To the duodenum: the mature MUCB, labeled with either [35Slsulfate or 13Hlgalactose, just entered the stacking gel and was also detected in the medium, displaying a very similar mobility (Fig. 3A) . This indicates that mature secreted MUC2 has the same mobility on SDS-PAGE as was shown for the duodenum in Fig. 2 , independent of its mode of labeling. In the ascending colon and sigmoid colon, [35S]sulfate-labeled mature MUC2 is detectable with a mobility of -600 kDa on SDS-PAGE in both the tissue and media homogenates (Fig. 3, B and C) , similar to the mobility of the mature MUC2 in the sigmoid colon after labeling with [35Slme-thioninejcysteine, as shown in Fig. 2 . On SDS-PAGE mobility of mature MUC2 did not vary between ascending colon, transverse colon, and sigmoid colon (not shown). However, between small and large intestine a clear difference in mobility on SDS-PAGE was observed for mature MUC2 (Fig. 3) , most likely due to a different glycosylation pattern. In the immunoprecipitated mature MUC2 from duodenum, an additional band can be observed at -600 kDa (double arrows in Fig. 3A ). These could be due to heterogeneity in glycosylation of MUC2 in the duodenum, where the 600-kDa band represents a small subpopulation of mature MUC2 that is similarly glycosylated as the mature MUC2 in the large intestine.
DISCUSSION
In this study we have demonstrated the biosynthesis of mucins in the gastrointestinal tract. With the use of metabolic labeling of gastrointestinal tissue, immunoprecipitation using mucin-specific antibodies, and analysis on SDS-PAGE we were able to discriminate between mucin precursors.
In the stomach, the detection of MUC5AC and MUC6 precursors was likely: high MUCSAC and MIX6 mRNA levels are reported for this organ (1,5,8,20,21,32,41) . Klomp et al. (22) showed that antibodies directed against purified rat or human gastric mucin immunoprecipitated mucin precursors with apparent M, 500,000 from human gastric tissue (22), similar to our findings with antibodies directed against a synthetic peptide of MUC5AC. We conclude that these antibodies all recognize the same mucin, namely, MUC5AC. We could not detect MUC6 precursors in the duodenum. Ho et al. (20) in the Brunner's glands, which are exclusively found in the duodenum. However, de Bolos and co-workers (8) did not detect MUC6 protein in the duodenum (8) . In the present study most biopsies do not contain functional Brunner's glands, possibly impeding the detection of MUCG. In the jejunum and colon no MUC6 precursors were detected, in accordance with immunohistochemical studies (20) and mRNA data (41). We detected MUC3 precursors in small but not large intestine and MUC2 precursors in both small and large intestine. This was expected, because the MUC3 mRNA level is high in small intestine but low in large intestine, whereas the MUC2 mRNA level is high throughout the intestinal tract (1,6,19,34,41) .
In the stomach, no immunoprecipitations of MUC2 were performed, but MUC2 mRNA had previously been shown to be virtually absent in this organ (1, 5, 41). MUC4 precursors were detected in the colon, and studies have suggested that MUC4 is also an abundant colonic mucin: MUC4 mRNA levels are high in the colon, but low or nil in the jejunum and stomach (1, 37,411. The mucin precursor MUC4, with apparent molecular mass >900 kDa, has the highest apparent molecular mass thus far identified. The biosynthesis of MUCl was not studied; MUCl has been shown to be expressed at low levels throughout the gastrointestinal tract and does not exhibit region-specific expression (5,41).
Each mucin studied shows a typical pattern of expression in the gastrointestinal tract: MUC2 is expressed in the small and large intestine, whereas MUC3 expression was confined to the small intestine; MUC4 is biosynthesized typically in the distal colon, whereas MUC5AC and MUC6 proteins are only expressed in the stomach. Moreover, these results were consistent in almost all individuals (Table 2) . In some individuals a mucin precursor may be deficient or synthesized at a very low level and may therefore escape detection. For instance, MUC4 precursor was not detected in the sigmoid colon of one individual.
Not much is known about the specific functions of each of the epithelial mucins. Mucins are generally thought to play a role in protecting the underlying epithelium from luminal noxae and mechanical stress (12,291. However, the regional distribution of MUC2-6 in the gastrointestinal tract indicates specific functions for these mucins. For instance, the gastric mucins at a position around 550-600 kDa on SDS-PAGE in both the sigmoid colon (34) and in LS 174T
and LS 180 cells, two colon adenocarcinoma cell lines (25,41). We showed that in small intestine the mobility on SDS-PAGE of mature secreted MUC2 is markedly different from that found in large intestine. In fact, the mobility of mature mucins is known to be aberrant on SDS-PAGE and depends largely on intrinsic negative charge, which is determined by terminally attached sialic acid and sulfate residues (38). Therefore, MUC2 may be glycosylated differently in small compared with large intestine.
However, more evidence of differences in 0-glycosylation could be obtained by structural analysis of MUC2 oligosaccharides after isolation of MUC2 from small and large intestine.
Variation in glycosylation between different regions of the intestine is likely, because the glycosyltransferases responsible for 0-glycosylation show tissue and cell-type-specific distributions (12, 29) . Glycosylation is important for the function of mucins, for instance, in bacterial interaction with mucus, because some bacteria can bind to mucin oligosaccharides, facilitating colonization by commensals or removal of pathogenic organisms (12, 35). Therefore, differences in the 0-glycan structure of mucins between small and large intestine may partially account for differences in bacterial flora and bacterial pathogenicity.
In addition, 0-glycans are important for gel formation (29). In conclusion, we have shown that mucin precursors of MUC2, MUC3, MUC4, MUC5AC, and MUC6 can be distinguished electrophoretically and exhibit regionspecific expression in the gastrointestinal tract. Moreover, it seems likely that some forms of allelic variation of MUC2 and MUC3 can be detected through expression of double bands of precursors in metabolic labeling experiments.
Differences in mobility of mature secreted MUC2 on SDS-PAGE between small and large intestine suggest differences in glycosylation of this mucin between these regions of the intestine. 
